MARK HESSELRODE: Open Payments
NPI 1164417127 · CORDOVA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,031 in 104 payments from 12 companies in 2025. Trend: 2023 $1,915 · 2024 $2,140 · 2025 $2,031
Food & beverage: $2,031
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $438 |
| Axsome Therapeutics, Inc. | 28 | $387 |
| Otsuka America Pharmaceutical, Inc. | 21 | $345 |
| Alkermes, Inc. | 10 | $328 |
| Vanda Pharmaceuticals Inc. | 11 | $163 |
| Janssen Pharmaceuticals, Inc | 5 | $115 |
| Supernus Pharmaceuticals, Inc. | 4 | $80 |
| ABBVIE INC. | 2 | $57 |
| Corium, LLC | 4 | $51 |
| Lundbeck LLC | 1 | $30 |
Products named: CAPLYTA, Auvelity, REXULTI, ARISTADA, LYBALVI, SPRAVATO, HETLIOZ, Qelbree.
Industry payments across TN — which companies pay providers there.
